Boehringer Ingelheim is a research-driven, leading global biopharmaceutical company committed to researching breakthrough therapies to transform lives and safeguard the health of generations. It creates value through innovation in areas of high unmet medical need. As an independent family-owned company since 1885, it focuses on long-term development across three business areas: Human Pharmaceuticals, Animal Health, and Biopharmaceutical Contract Manufacturing.
